Last updated on June 2019

Safety Tolerability Pharmacokinetics and Activity of K0706

Brief description of study

Phase 1/2 study to determine safety, tolerability, pharmacokinetics and activity of K0706

Detailed Study Description

Part A ( for Healthy volunteers) of the study is completed Part B (for CML subject ) of the study is ongoing. (Recruitment for Part B initiated in April 2017) Part C of study in subjects with CML and Ph+ ALL is on-going. (Open for Recruitment )

Clinical Study Identifier: NCT02629692

Find a site near you

Start Over

SPARC Site 6

Toulouse Cedex 9, France
  Connect »